ERG-1 Peptides and Polynucleotides and their Use in the Treatment and Diagnosis of Disease

The present invention relates to peptide and polynucleotide fragments of ERG-1, and in particular, human ERG-1a (HERG-1a) and its isoforms, and their use in the treatment and diagnosis of disease, especially cardiac diseases, such as arrhythmias, and cancer.

Attached files:


Patents:
US 20,090,047,703

Inventor(s): TRUDEAU MATTHEW C [US]

Type of Offer: Licensing



« More Biotech Patents

---